Raquel Ferreira is “Investigadora FCT” at CICS-UBI, University of Beira Interior (Covilhã, Portugal). From 2006 to 2011, she conducted her studies on the modulatory role of neuropeptide Y in microglia activity. Then, she determined the involvement of histamine and its receptors on microglia inflammatory responses, using histamine-loaded microparticles. From 2012 to 2013, she pursued her Post-Doctoral studies in the field of human brain angiogenesis at the University of Southern California (USA), focusing on the role of miR-18a in human cerebral arteriovenous malformation-derived endothelial cell function, and in 2014 moved to University of Beira Interior as Post-Doc Research Fellow, where her main focus was to study a therapeutic approach to stroke using retinoic acid-loaded nanoparticles to repair the brain vasculature and enhance neurovascular and functional repair. Her current research is focused in the application of biomaterials to treat neurovascular disorders. Raquel Ferreira has more than 30 papers in international peer reviewed (ISI) journals, 2 patents, 4 book chapters, and an e-book. She supervised to completion 4 MSc thesis. Currently supervising a PhD student who received an FCT doctoral grant. She was awarded several distinctions, namely the Medal Honor L’Oreal Portugal for Women in Science, a Research Grant from SPAVC - Portuguese Stroke society, and a BD Biosciences Immunology Grant. She is part of the book “Mulheres na Ciência” [Women in Science], an homage to Portuguese women scientists by Ciência Viva national agency.